πŸ‡ΊπŸ‡Έ FDA
Patent

US 9428541

Substrate reduction therapy

granted A61KA61K31/195A61K31/197

Quick answer

US patent 9428541 (Substrate reduction therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/40, A61K31/42